Cambodia, Laos, and Myanmar are all heavily reliant on imported pharmaceutical products. A strong economic outlook in Cambodia and the introduction of universal healthcare coverage in Laos are both expected to drive growth in the pharmaceutical sector. While economic uncertainty continues to hamper growth in Myanmar, medicine shortages are giving rise to significantly increased demand.

In this webinar, David Mol, a Senior Associate in Tilleke & Gibbins’ Cambodia office, Dino Santaniello, Head of Tilleke & Gibbins’ Laos office, and Aye Thuzar Hlaing, a Senior Associate in Tilleke & Gibbins’ Myanmar office, will provide an overview of the regulatory framework for the importation of pharmaceutical products in their three countries, including the requirements for obtaining marketing authorization.

Other sessions:

• Marketing Authorization and Regulatory Requirements for Exporting Drugs to Thailand
• Understanding Regulatory Requirements for Exporting Drugs to Indonesia and Vietnam

Contents

Cambodia

1. Cambodia Pharmaceutical Market Outlook

2. Regulatory Framework and Competent Authority

• 2.1 Legislation update
• 2.2 Competent authorities

3. Drug Product Requirements

• 3.1 Definitions and classifications
• 3.2 Good Manufacturing Practices (GMPs) and overseas manufacturing sites
• 3.3 Obtaining a marketing authorization license

Laos

1. Laos Pharmaceutical Market Outlook

2. Regulatory Framework and Competent Authority

• 2.1 Legislation update
• 2.2 Competent authorities

3. Drug Product Requirements

• 3.1 Definitions and classifications
• 3.2 Good Manufacturing Practices (GMPs) and overseas manufacturing sites
• 3.3 Obtaining a marketing authorization license

Myanmar

1. Myanmar Pharmaceutical Market Outlook

2. Regulatory Framework and Competent Authority

• 2.1 Legislation update
• 2.2 Competent authorities

3. Drug Product Requirements

• 3.1 Definitions and classifications
• 3.2 Good Manufacturing Practices (GMPs) and overseas manufacturing sites
• 3.3 Obtaining a marketing authorization license